Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.

Clinical trial NCT04027530 · COMPLETED

Trial details

NCT number: NCT04027530
Sponsor: Amsterdam UMC, location VUmc
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus Diabetic Kidney Disease Diabetic Nephropathy Renal Hypoxia Renoprotection SGLT2 Inhibitor Ertugliflozin

Start date: 2020-12-10
Primary completion: 2023-01-09
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.